DK131721B - Analogous process for the preparation of adamantanylamines or 3,5,7-trimethylhomologous or acid addition salts thereof. - Google Patents

Analogous process for the preparation of adamantanylamines or 3,5,7-trimethylhomologous or acid addition salts thereof.

Info

Publication number
DK131721B
DK131721B DK457869AA DK457869A DK131721B DK 131721 B DK131721 B DK 131721B DK 457869A A DK457869A A DK 457869AA DK 457869 A DK457869 A DK 457869A DK 131721 B DK131721 B DK 131721B
Authority
DK
Denmark
Prior art keywords
trimethylhomologous
adamantanylamines
preparation
acid addition
addition salts
Prior art date
Application number
DK457869AA
Other languages
Danish (da)
Other versions
DK131721C (en
Inventor
C H Cashin
S S Szinai
J K Chakrabarti
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DK131721B publication Critical patent/DK131721B/en
Application granted granted Critical
Publication of DK131721C publication Critical patent/DK131721C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • C07C53/138—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems containing an adamantane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/38—Acyl halides
    • C07C53/44—Acyl halides containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/36—Acyl halides
    • C07C55/38—Acyl halides containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Pivots And Pivotal Connections (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DK457869A 1968-08-27 1969-08-26 ANALOGICAL PROCEDURE FOR THE PREPARATION OF ADAMANTANYLAMINES OR 3,5,7-TRIMETHYL HOMOLOGE OR ACID ADDITIONAL SALTS THEREOF DK131721C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40968/68A GB1274652A (en) 1968-08-27 1968-08-27 Adamantanyl-alkylamine derivatives and their preparation

Publications (2)

Publication Number Publication Date
DK131721B true DK131721B (en) 1975-08-25
DK131721C DK131721C (en) 1976-01-26

Family

ID=10417493

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457869A DK131721C (en) 1968-08-27 1969-08-26 ANALOGICAL PROCEDURE FOR THE PREPARATION OF ADAMANTANYLAMINES OR 3,5,7-TRIMETHYL HOMOLOGE OR ACID ADDITIONAL SALTS THEREOF

Country Status (12)

Country Link
JP (3) JPS4939257B1 (en)
AT (1) AT307380B (en)
BE (1) BE737975A (en)
CH (3) CH553149A (en)
DE (1) DE1943404A1 (en)
DK (1) DK131721C (en)
FR (1) FR2016468B1 (en)
GB (1) GB1274652A (en)
IE (1) IE33929B1 (en)
IL (1) IL32892A (en)
NL (1) NL6913046A (en)
SE (1) SE364037B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS507356A (en) * 1973-05-22 1975-01-25
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103836D0 (en) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
SE0300480D0 (en) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
ITTO20030668A1 (en) * 2003-09-02 2005-03-03 Rotta Res Lab S P A O Ra Rottapharm DERIVATIVES OF ADAMANTAN EQUIPPED WITH NEUROPROTECTIVE, ANTIDEPRESSIVE AND ANTI-ISCHEMIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION.
ES2388454T3 (en) 2007-03-22 2012-10-15 Astrazeneca Ab Quinoline derivatives for the treatment of inflammatory diseases
PE20091036A1 (en) 2007-11-30 2009-08-15 Astrazeneca Ab QUINOLINE DERIVATIVE AS ANTAGONIST OF THE P2X7 RECEPTOR
CN109593042B (en) * 2018-12-24 2021-12-07 陕西莱特迈思光电材料有限公司 Organic electroluminescent material and organic electroluminescent device comprising same
CN114181091B (en) * 2021-12-27 2024-06-14 维思普新材料（苏州）有限公司 Synthesis process of adamantane triphenylamine

Also Published As

Publication number Publication date
FR2016468B1 (en) 1973-06-08
AT307380B (en) 1973-05-25
CH551365A (en) 1974-07-15
FR2016468A1 (en) 1970-05-08
SE364037B (en) 1974-02-11
JPS4939256B1 (en) 1974-10-24
JPS5010856B1 (en) 1975-04-24
GB1274652A (en) 1972-05-17
DE1943404A1 (en) 1970-12-17
IE33929L (en) 1970-02-27
DK131721C (en) 1976-01-26
IL32892A (en) 1975-04-25
JPS4939257B1 (en) 1974-10-24
CH553149A (en) 1974-08-30
BE737975A (en) 1970-02-26
IL32892A0 (en) 1969-11-12
CH538442A (en) 1973-06-30
IE33929B1 (en) 1974-12-11
NL6913046A (en) 1970-03-03

Similar Documents

Publication Publication Date Title
DK124884B (en) Analogous process for the preparation of 2-bromo-α-ergocryptine or acid addition salts thereof.
DK134984B (en) Analogous process for the preparation of alpha-alkylaminopropiophenones or acid addition salts thereof.
DK130070B (en) Analogous process for the preparation of 3,4-dihydroxyphenylalkanolamines or acid addition salts thereof.
DK115473B (en) Process for the preparation of 2,3,4,5-tetrahydro-1H-3-benzazepines or acid addition salts thereof.
DK139717B (en) Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof.
DK124404B (en) Process for the preparation of 2-arylamino-1,3-diazacycloalkenes (2) or acid addition salts thereof.
DK136526B (en) Analogous process for the preparation of substituted naphthylalkylamines or acid addition salts thereof.
DK131721B (en) Analogous process for the preparation of adamantanylamines or 3,5,7-trimethylhomologous or acid addition salts thereof.
DK137382B (en) Analogous process for the preparation of 2,2-diaryl-4- (4'-aryl-4'-hydroxy-piperidine) butyramides or acid addition salts thereof.
DK129577B (en) Analogous process for the preparation of phenacetylguanidines or acid addition salts thereof.
DK127644B (en) Analogous process for the preparation of ergopeptins or acid addition salts thereof.
DK129448B (en) Analogous process for the preparation of bis- (benzylideneamino) -guanidines or acid addition salts thereof.
DK129994B (en) Analogous process for the preparation of 1-trimethoxybenzyl-6,7-dialkanoyl-1,2,3,4-tetrahydroisoquinolines or acid addition salts thereof.
DK120155B (en) Analogous process for the preparation of aminopropiophenones or acid addition salts thereof.
DK121367B (en) Analogous process for the preparation of 3,3-diphenylallylamine derivatives or acid addition salts thereof.
DK126327B (en) Analogous process for the preparation of derivatives of p-aminoalkylbenzenesulfonamide or acid addition salts thereof.
DK121123B (en) Process for the preparation of 1,2-dihydro-4-phenyl-quinazoline-3-oxides or acid addition salts thereof.
DK135231B (en) Analogous process for the preparation of basic substituted 2,3-cis, trans-diphenylcyclopropane derivatives or acid addition salts thereof.
DK138015B (en) Process for the preparation of substituted N-cycloalkyl-arylamino-imidazolines (2) or acid addition salts thereof.
DK127424B (en) Analogous process for the preparation of 4-aryl-1- (4,4-diarylbutyl) -4-hydroxypiperidines or acid addition salts thereof.
DK118663B (en) Analogous process for the preparation of basic substituted derivatives of 5,6-dihydro-dibenz- [b, e] -azepine-6,11-dione-11-oxime or acid addition salts thereof.
DK129454B (en) Analogous process for the preparation of ergonorcornine or acid addition salts thereof.
DK137044B (en) Analogous process for the preparation of 4,4-diphenylhexahydroazepine derivatives or acid addition salts thereof.
DK131727B (en) Analogous process for the preparation of oxazinobenzoxazines or acid addition salts thereof.
DK121955B (en) Analogous process for the preparation of 1,4-substituted phenylpiperazines or acid addition salts thereof.